Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
11/13/2003 | WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases |
11/13/2003 | WO2003024448A3 Inhibitors of histone deacetylase |
11/13/2003 | WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
11/13/2003 | WO2002083622A3 Novel aminophenyl ketone derivatives |
11/13/2003 | WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors |
11/13/2003 | WO2002002520A8 Compounds to treat alzheimer's disease |
11/13/2003 | US20030212140 Analgesics; central nervous system disorders |
11/13/2003 | US20030212116 Contorlling plant disease |
11/13/2003 | US20030212111 Controlling concentration of cholesterol, triglyceride, bile acid |
11/13/2003 | US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents |
11/13/2003 | US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents |
11/13/2003 | US20030211560 Bioluminescent protease assay |
11/13/2003 | CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
11/13/2003 | CA2484582A1 Bombesin antagonists |
11/13/2003 | CA2484065A1 Inhibitors of histone deacetylase |
11/13/2003 | CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
11/12/2003 | EP1361221A1 A process for the preparation of a combination of famotidine polymorphs A and B |
11/12/2003 | EP1361220A1 Cyclic compounds having thrombopoietin receptor agonism |
11/12/2003 | EP1360901A1 2,3-cyclic substituted derivatives of 3-hydroxyacrolein and 3-hydroxyacrylic acid as pesticides |
11/12/2003 | EP1360179A2 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin |
11/12/2003 | EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds |
11/12/2003 | EP1240164B1 Benzazole derivatives and their use as jnk modulators |
11/12/2003 | EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators |
11/12/2003 | EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof |
11/11/2003 | US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
11/11/2003 | US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
11/11/2003 | US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases |
11/11/2003 | US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis |
11/11/2003 | US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment |
11/11/2003 | CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
11/11/2003 | CA2264268C Novel peptide derivatives having thiazolyl-alanine residue |
11/11/2003 | CA2133579C Synergistic composition and process for selective weed control |
11/06/2003 | WO2003091675A2 Ultrasonic doppler effect speed measurement |
11/06/2003 | WO2003091231A1 Pna monomer and precursor |
11/06/2003 | WO2003091230A1 Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate |
11/06/2003 | WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient |
11/06/2003 | WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis |
11/06/2003 | WO2003016270A3 Selective estrogen receptor modulators |
11/06/2003 | WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors |
11/06/2003 | WO2002026737A8 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
11/06/2003 | US20030208080 Synthesis of epothilones, intermediates thereto and analogues thereof |
11/06/2003 | US20030208067 Inhibitors of protein kinase for the treatment of disease |
11/06/2003 | US20030208065 Reacting 7-amino-3-vinylceph-3-em-4-carboxylic acid with 2-(2-amino-4-thiazolyl-2(aryl or alkyl)oxycarbonylmethyoxy-iminoacetylthio-)benzothiazole to obtain Cefixime; salt formation with tert-octylamine; crystal structure |
11/06/2003 | US20030207924 Compounds that modulate PPAR activity and methods of preparation |
11/06/2003 | US20030207921 For treatment of HIV infection, including non-nucleoside inhibitor-resistant, and multi-drug resistant strains of HIV |
11/06/2003 | US20030207916 Thiazole or oxazole derivatives such as (4-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-5-oxo -5,6,7,8-tetrahydro-naphthalen-1-yloxy)-acetic acid |
11/06/2003 | US20030207915 Compounds that modulate PPAR activity and methods of preparation |
11/06/2003 | US20030207894 1,4-Disubstituted benzenes as insecticides |
11/06/2003 | US20030207877 Pyridoquinoxaline antivirals |
11/06/2003 | US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
11/06/2003 | US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
11/06/2003 | US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus |
11/06/2003 | CA2483482A1 Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate |
11/06/2003 | CA2454612A1 Ultrasonic doppler effect speed measurement |
11/05/2003 | EP1358169A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
11/05/2003 | EP1358144A1 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
11/05/2003 | EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
11/05/2003 | EP0902007B1 Chalcone derivatives and drugs containing the same |
11/05/2003 | CN1126747C Novel 2-aminothiazol-fused 2-aminoindans and 2-aminotetralines and application thereof |
11/05/2003 | CN1126746C Process for producing 2-chloro-5-chloromethyl thiazole |
11/04/2003 | US6642388 Method for producing 2-aminomethyl-4-cyano-thiazol |
11/04/2003 | US6642379 Containing oxazolyl, thiazolyl or imidazolyl groups |
11/04/2003 | US6642263 Modulators of Rho C activity |
11/04/2003 | US6642260 Nitric oxide donors and pharmaceutical compositions containing them |
11/04/2003 | US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide |
11/04/2003 | US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer. |
11/04/2003 | US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug |
11/04/2003 | US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation |
11/04/2003 | CA2257322C Thiazole derivatives |
11/02/2003 | CA2426122A1 A process for the preparation of a combination of famotidine polymorphis a and b |
10/30/2003 | WO2003089419A1 New 2-substituted -1,3-thiazole compounds |
10/30/2003 | WO2003089418A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
10/30/2003 | WO2003044877A3 Light emitting device and compounds for use therein |
10/30/2003 | WO2003043577A3 Modulators of rho c activity |
10/30/2003 | WO2002069961A8 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
10/30/2003 | US20030204095 Reducing thiazole ester to thiazole alcohol using sodium borohydride in the presence of aluminum chloride in a solvent and oxidising the thiazole alcohol to obtain 4-methyl-5-formyl-thiazole |
10/30/2003 | US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
10/30/2003 | US20030203950 2-Phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same |
10/30/2003 | US20030203948 Compounds having anti-hepatitics c virus effect |
10/30/2003 | US20030203947 Activator of PPAR delta |
10/30/2003 | US20030203946 Glucagon antagonists/inverse agonists |
10/30/2003 | US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal |
10/30/2003 | US20030203941 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus |
10/30/2003 | US20030203913 Beta3 adrenergic receptor agonists and uses thereof |
10/30/2003 | US20030203907 Novel pyrazinone derivatives |
10/30/2003 | US20030203897 2,4-Disubstituted thiazolyl derivatives |
10/30/2003 | US20030203891 A veterinary medicine for controlling parasites and pests on animals |
10/30/2003 | US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction |
10/30/2003 | CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
10/30/2003 | CA2480451A1 New 2-substituted -1,3-thiazole compounds |
10/29/2003 | EP1357116A1 2-acylaminothiazole derivative or its salt |
10/29/2003 | EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof |
10/29/2003 | EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
10/29/2003 | EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
10/29/2003 | EP1355891A2 Therapy |
10/29/2003 | EP1355879A1 Carboxamides as fungicides in agriculture |
10/29/2003 | EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
10/29/2003 | EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
10/29/2003 | EP1089964B1 Hydrazine derivatives |
10/29/2003 | EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |